IDF 2019 Programme Chair & Stream Leads

Chair: Edward J. Boyko, USA

E Boyko

Edward Boyko, MD, MPH, is Professor of Medicine and Adjunct Professor of Epidemiology at the University of Washington and Staff Physician at VA Puget Sound Health Care System in Seattle. He received his BA degree from Columbia University in 1975 and his MD degree from the University of Pittsburgh in 1979. He completed an internal medicine internship and residency at the University of Chicago in 1982, and fellowship training in the Robert Wood Johnson Clinical Scholars Program in Seattle in 1984. He is the founding and former Director of the VA-funded Seattle Epidemiologic Research and Information Center (ERIC). He has held several national positions including Associate Editor of the journals Diabetes Care and the American Journal of Epidemiology; former Chair of the NIH Kidney, Nutrition, Obesity, and Diabetes (KNOD) study section; Chair of the ADA Epidemiology and Statistics Interest Group; Member of the ADA Scientific Sessions Planning Committee; Public Health and Epidemiology Deputy Stream Lead for the 2013 World Diabetes Congress held in Melbourne, Australia; Public Health and Epidemiology Stream Lead for the 2015 World Diabetes Congress held in Vancouver, Canada; and past President of the International Diabetes Epidemiology Group. Dr Boyko’s research programme focuses on the epidemiology type 2 diabetes and its complications, associated metabolic disorders, and obesity. Dr Boyko’s best-known research was conducted in the Japanese American Community Diabetes Study, a prospective study that followed Japanese-American residents of King County, Washington State for 10 years for the development of diabetes and related conditions. In 2013, he received the Kelly West Award from the American Diabetes Association in recognition of his significant contributions to the field of diabetes epidemiology. In addition to his research interests, he also provides care for a primary care patient panel at VA Puget Sound in Seattle. He has mentored over 50 trainees and junior faculty members over the course of his career. In 2004 he received the University of Washington Medicine Award for Outstanding Mentorship.

Basic and Translational Science Stream Lead: Young-Bum Kim, USA

YB KimDr Kim is currently an Associate Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center. His training included two master’s degree, one from the Kon-Kun University in Korea and the other from University of Tsukuba in Tsukuba, Japan where he also received his PhD in Molecular Physiology. Dr Kim is interested in human metabolism because of the crucial roles that glucose and energy homeostasis play in health and disease. His research focuses on identifying the molecular mechanisms mediating the metabolic action of insulin and leptin, and the resistance to these hormones that underlies diseases such as obesity and diabetes. To identify the metabolic roles of specific molecular signals, his lab uses genetically engineered mouse models and cultured cell systems, in conjunction with biochemical, molecular, and physiological techniques. Using these techniques, he found that Rho-kinase regulates insulin-stimulated glucose transport and signaling via either IRS-1 serine phosphorylation or actin polymerization, and also controls energy balance by targeting leptin receptor signaling, establishing a new mechanism for the regulation of insulin and leptin action. He is also an editorial board member for Diabetes, Journal of Biological Chemistry, Molecular Metabolism, the American Journal of Physiology and Endocrinology, an associate editor of Metabolism and serves on the research grant review panel of the NIH, American Diabetes Association, Endocrine Society and several international funding agencies.

Clinical and Therapeutic Research Stream Lead: Raimund Weitgasser, Austria

R WeitgasserDr Raimund Weitgasser is Professor of Medicine, Department of Internal Medicine at Wehrle-Diakonissen Hospital Salzburg which, besides general internal medicine, specialises in diabetology, cardiology, gastroenterology and nephrology. Furthermore he serves as a researcher and lecturer at Paracelsus Medical University Salzburg, Austria. He earned an M.D. degree from Innsbruck University Medical School. At Salzburg General Hospital he was an intern and resident. He served as a research associate at Unit of Metabolic Medicine, Guy´s Hospital, University of London, UK and as a research associate and lecturer at Joslin Diabetes Center, Harvard University Medical School, Boston, USA. He earned specialty degrees in cardiology, endocrinology & metabolism and gastroenterology & hepatology. His research interests are clinical diabetology (e.g pharmacotherapy, diabetes technology, disease management), islet transplantation and immunology. He has published more than 300 articles and abstracts and has given over 490 lectures mainly in the field of diabetology and metabolism. As Past President of the Austrian Diabetes Association (ÖDG), Council Member (currently Honorary Treasurer) of the European Association for the Study of Diabetes (EASD) and currently Austrian Delegate at the International Diabetes Federation (IDF) he is engaged in national and international programmes for diabetes care and advanced education (e.g. member of the program committee for EASD and IDF congresses).

Diabetes and Women Stream Lead: Ronald Ma - Hong Kong, China

R MaRonald Ching Wan Ma is Professor at the Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Honorary Consultant Physician and Division Head of Diabetes and Endocrinology, Prince of Wales Hospital, Hong Kong. Dr Ma completed his medical training at the University of Cambridge, UK and trained in Internal Medicine in London. Through support from a Croucher Foundation Fellowship, he furthered his research interest at the Joslin Diabetes Center, Harvard Medical School, Boston, USA, under the mentorship of Professor George King. Dr Ma’s research focuses on the epidemiology and genetics of diabetes and its complications, gestational diabetes, polycystic ovary syndrome, and the developmental origins of diabetes. He is currently leading a mutli-disciplinary project team to leverage on the large Hong Kong Diabetes Register and accompanying biobank to identify novel molecular markers for diabetic complications, and is the principal investigator of the newly established Hong Kong Diabetes Biobank. He is also undertaking studies to investigate the long-term effects of GDM, using several long-term cohorts. He has published over 250 research articles in international peer-reviewed journals and authored 12 book chapters. Dr Ma is a recipient of several awards, including the Young Investigator Award from the International Diabetes Epidemiology Group (IDEG), Ten Outstanding Young Persons Award, Hong Kong (2009), the Albert Renold Fellowship from the European Association for the Study of Diabetes (2010), the Research Excellence Award (2011) and the Outstanding Fellowship of Faculty of Medicine from the Chinese University of Hong Kong (2014). Dr Ma has served on several local and international bodies. He is a Past President of the International Diabetes Epidemiology Group (IDEG), the Hong Kong Society of Endocrinology, Metabolism and Reproduction (HKSEMR) and Diabetes Hongkong (DHK). He currently serves on the Executive Board, the Asian Association for the Study of Diabetes (AASD), the Council of the International Society for Developmental Origins of Health and Disease (DOHaD), the FIGO Committee on Pregnancy and NCD Prevention, and the Lancet Commission on Diabetes. He has recently served on the World Health Organization Working Group on Science and Evidence to End Childhood Obesity (ECHO). He is an Associate Editor of Diabetic Medicine, and editorial board member of PLoS Medicine, Obesity Reviews, Nutrition, Metabolism and Cardiovascular Diseases, and assistant editor of the Journal of Diabetes Investigation.

Diabetes Complications and Comorbidities Stream Lead: Peter Rossing, Denmark

P RossingProfessor Peter Rossing, MD DMSc, is a clinician researcher devoted to complications in diabetes with focus on renal and cardiovascular complications. He obtained a specialist degree in internal medicine and endocrinology in 2004. Since 2007, he has been a chief physician and manager of the Steno Diabetes Center research team dedicated to the research of micro-and macrovascular complications of diabetes. Since 2012, he is a professor of diabetic angiopathy at University of Copenhagen. Peter Rossing has, in epidemiological studies, investigated key features of the pathophysiology of the diabetic kidney at different stages. He has identified several markers for development of diabetic nephropathy, making it possible to predict the individual risk. He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis. He is coordinator of the EU FP7 project PRIORITY aiming to test if urinary proteomics can be used to stratify prevention of renal complications in type 2 diabetes, and the Novo Nordisk Foundation grant PROTON aiming at personalising prevention of diabetic nephropathy. He has co-authored over 300 papers and his h-index is 57. He received the Minkowski prize in 2005 and the Golgi prize in 2016 both from the EASD. He is past president of the Danish Endocrine Society, and of the European Diabetic Nephropathy Study group and chairman of the Danish National Diabetes Registry.

Diabetes in Society and Culture Stream Lead: Kun-Ho Yoon - Korea

KH YoonKun-Ho Yoon is Professor in the Department of Endocrinology & Metabolism at Seoul St Mary’s Hospital and Chief of the Department of Medical Informatics, Catholic University Medical College, Korea. Professor Yoon graduated with his medical degree and also pursued his PhD programme at the Catholic University Medical College. Professor Yoon also completed a 2-year stint as a visiting scholar with the cell biology and islet transplantation section in Joslin Diabetes Center of Harvard Medical School from 1996 to 1998. Professor Yoon was the recipient of the Korean Diabetes Association (KDA) Scientific Award three times. He was honoured with the Health Technology Award by the of Ministry of Health and Welfare and the Innovative ICT and Healthcare Award by it’s president. Professor Yoon has published more than 200 articles in international peer-reviewed journals with recent publications in the Lancet, JAMA, Cell Metabolism, Diabetes Care, Diabetes, inter alia. His research has been focused on the beta-cell biology and improved diabetes patients care using the mobile and internet platforms. He also led the development of the treatment guidelins of diabetes by KDA and he served as a Vice President of KDA.   He had served as Executive Director, Bureau of HT R&D Planning and Budget Management of the Korea Health Industry Development Institute for two years.

Education and Integrated Care Stream Lead: Sue McLaughlin, USA

S McLaughlinSue McLaughlin, MOL, BS, RDN,CDE, LMNT, has been a registered dietitian nutritionist and certified diabetes educator for over 25 years and practices at Nebraska Medicine, Children’s Hospital Diabetes and Endocrine Clinics, and with the Winnebago Tribe of Nebraska. She is an adjunct instructor in the UNMC College of Allied Health Professions and preceptor for students in the UNMC Dietetic Internship Program. She is also Director of Nutrition at Camp Floyd Rogers, summer camp for children and teens with type 1 diabetes. Sue received her BSc degree in human nutrition from the University of Nebraska-Lincoln, completed the dietetic internship programme at Mayo Clinic/St Marys Hospital in Rochester, Minnesota, and her master’s degree in organisational leadership from College of St Mary in Omaha, Nebraska. Work experiences have included nutrition and diabetes education for paediatric and adult populations in multiple settings, including the Diabetes Prevention Program with the Winnebago Tribe, home care, long-term care, private practice, clinics, and inpatient and outpatient hospital settings. Leadership positions have included: 2013 – 2015 Chair, Diabetes Education Consultative Section, IDF; Deputy Lead, Education and Integrated Care Stream, 2015 IDF World Diabetes Congress; 2015 Chair of the Board, National Certification Board for Diabetes Educators; 2009 National President, Health Care and Education, American Diabetes Association (ADA); and 1997 Chair, Diabetes Care and Education (DCE), Academy of Nutrition and Dietetics (AND). Sue has authored and edited numerous publications, including: the IDF International Standards for Diabetes Education of Health Professionals; Associate Editor, American Association of Diabetes Educator’s The Art and Science of Diabetes Self-Management Education Desk Reference; Editor, DCE’s On The Cutting Edge peer-reviewed newsletter; and Associate Editor, Diabetes Forecast. She is the recipient of several awards, including ADA’s Rachmiel Levine Award for Outstanding Volunteer Service (2009); the Nebraska AND’s Outstanding Dietitian (1999) and Recognized Young Dietitian of the Year (1991) Awards; and DCE’s Distinguished Service Award (2000).

Epidemiology and Public Health Stream Lead: Anthony Hanley, Canada

A HanleyDr Anthony Hanley received his PhD in epidemiology in 2000 from the University of Toronto with Professors Gail Eyssen and Bernard Zinman. He subsequently completed a post-doctoral fellowship with Dr Steve Haffner at the University of Texas Health Sciences Centre in San Antonio, Texas. From 2002-2005, Dr Hanley was a research scientist at the Leadership Sinai Centre for Diabetes at Mt. Sinai Hospital, Toronto. Dr Hanley is currently a faculty member in the Department of Nutritional Sciences, University of Toronto where he teaches, conducts research, and supervises graduate students. His research is supported by the Canadian Institutes for Health Research, the Canadian Diabetes Association, Dairy Farmers of Canada, and the University of Toronto Banting and Best Diabetes Centre. He held a Canada research chair in diabetes epidemiology from 2006-2016. Dr Hanley has established an innovative programme of research in the metabolic and nutritional epidemiology of type 2 diabetes and its underlying physiological traits, including insulin resistance and pancreatic beta cell dysfunction. His work focuses on longitudinal cohorts of understudied high-risk populations, including Indigenous Canadians, those of African and Hispanic origin, and non-diabetic subjects who are otherwise at very high risk of progression to diabetes, including those with pre-diabetes or the metabolic syndrome.

Living with Diabetes Stream Lead: Renza Scibilia - Australia

R ScibiliaRenza Scibilia has lived with type 1 diabetes since April 1998. She is a well-known diabetes patient advocate and activist, promoting a person-centred approach to healthcare, and in the development of diabetes information, services and technologies. Renza has worked in diabetes organisations for over 16 years and is currently the Manager of Type 1 Diabetes and Consumer Voice at Diabetes Australia. Previously, she was the Consumer Engagement Manager at a Diabetes Australia state-based organisation where she established and managed Australia’s first consumer-led and consumer-focused diabetes program, offering support, information and peer connections for people with diabetes and their families. Renza is an active and well-known member of the diabetes online community (DOC). She’s well-versed in social media and its application in diabetes peer support. Renza is the creator and author of her own diabetes blog where she writes about issues of interest to people living with diabetes. The blog, Diabetogenic (, has received awards for excellence in health writing, and is one of Australia’s most widely-read consumer patient blogs. She is also a frequent contributor to health publications. Renza is a regular invited speaker at health professional, industry and patient conferences around the world, where she speaks about: why the language we use is important in healthcare; how online platforms are used to improve consumer engagement with healthcare professionals and industry; the role of people with diabetes in the design and development of health programs; and the significance of peer support.

© 2019 International Diabetes Federation Disclaimer